BillionToOne, Inc. splits its revenue into 3 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Prenatal at $104.3 million, 85% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
|---|---|---|---|---|---|---|
| Revenue |
437
|
123
|
109
|
108
|
96
|
84
|
| Prenatal |
381
+62.7%
share 87.2%
|
104
+40.8%
share 84.8%
|
94
share 86.1%
|
97
share 89.1%
|
86
share 89.6%
|
74
share 88.7%
|
| Oncology |
51
+199.1%
share 11.6%
|
17
+96.2%
share 13.9%
|
14
share 12.5%
|
11
share 9.9%
|
9
share 9.5%
|
9
share 10.4%
|
| Clinical Trial Support And Other Services |
5
+70.5%
share 1.2%
|
2
+115.2%
share 1.3%
|
2
share 1.4%
|
1
share 1.1%
|
1
share 0.8%
|
1
share 0.9%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BLLN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Menlo Park, CA
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2070849
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- CareDx, Inc. CDNA
Source: SEC EDGAR filings. This is company-reported data, not investment advice.